| Hypothesis: Cystic fibrosis carrier geography reflects interactions of tuberculosis and hypertension with vitamin D deficiency, altitude and temperature. Vitamin D deficiency effects and cf carrier advantage. | |
| | |
MedLine Citation:
|
PMID: 21968085 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Interactions between selective factors (hypertension and tuberculosis) and environmental effects (vitamin D deficiency [VDD], temperature, and altitude) largely explain cystic fibrosis (CF) carrier geography. For VDD sequelae such as hypertension and tuberculosis vulnerability, clinical evidence of carrier protection is supported by indications that decreased CF arylsulfatase B activity suppresses tuberculosis, and that excess CF salt loss decreases blood pressure. A need for salt retention in the tropics selected against CF carriers despite possible advantages against cholera, typhoid, and other factors, but salt retention was less important elsewhere. Increased hypertension with cold selected for carriers with increasing latitude, and with altitude, where hypertensive complications of pregnancy also rise. ΔF508 rates especially seem to follow these parameters, and may be particularly protective against hypertension, while lower rates in Ashkenazi Jews are consistent with a greater role for tuberculosis in this group. This scenario suggests geographical correlations of CF with other genes affecting blood pressure, and significant carrier levels, especially of ΔF508, in mountainous areas of Asia with VDD. |
| | |
Authors:
|
Mark Lubinsky |
Related Documents
:
|
15757615 - Effect of serum albumin on qrs wave amplitude in patients free of heart disease. 707295 - Effect of afterload reduction on plasma volume during acute heart failure. 1579875 - The fluid content of the human intervertebral disc. comparison between fluid content an... 18379535 - Echocardiographic, electrocardiographic and blood pressure changes induced by icodextri... 2499195 - Pathophysiology of pressure changes during intrauterine transfusion. 1905595 - Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolera... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-1 |
Journal Detail:
|
Title: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Volume: - ISSN: 1873-5010 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101128966 Medline TA: J Cyst Fibros Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Simvastatin induces the expression of hemeoxygenase-1 against ischemia-reperfusion injury on the tes...
Next Document: MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fi...